6-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2020

Commission File Number 1-14840

 

 

AMDOCS LIMITED

 

 

Hirzel House, Smith Street,

St. Peter Port, Island of Guernsey, GY1 2NG

Amdocs, Inc.

1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

FORM 20-F ☒         FORM 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

YES ☐         NO ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______

 

 


On November 10, 2020, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended September 30, 2020. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.

The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

AMDOCS LIMITED

 

By:  

/s/ Matthew E. Smith

  Matthew E. Smith
  Secretary and Authorized Signatory

Date: November 10, 2020


EXHIBIT INDEX

 

EXHIBIT
NO.

  

DESCRIPTION

99.1    Amdocs Limited Press Release dated November 10, 2020.
EX-99.1

Exhibit 99.1

 

LOGO

Amdocs Limited Reports Fourth Quarter Fiscal 2020 Results

Record Quarterly Revenue of $1.05 Billion

Expects Acceleration in Fiscal 2021 Revenue Growth to 4.0%-8.0% YoY

as Reported and 3.5%-7.5% in Constant Currency

Accelerates Growth Strategy and Business Focus Around Cloud and 5G

with Strategic Partnerships, Closing Openet Acquisition and the

Expected Divestiture of OpenMarket for Approximately $300 Million

Fourth Quarter Fiscal 2020 Highlights

 

   

Closed the previously announced acquisition of Openet on August 11, 2020

 

   

Today signed an agreement for the divestiture of OpenMarket, an Amdocs subsidiary, for approximately $300 million cash with Infobip, a company in which One Equity Partners is the primary institutional investor

 

   

Revenue of $1,053 million. After adjusting for a positive impact from foreign currency movements of approximately $7 million compared to our guidance assumptions, and revenue from Openet, which was not included in the fourth quarter guidance range, revenue was slightly above the midpoint of the $1,015-$1,055 million guidance range

 

   

Record managed services revenue of $611 million, up 4.8% as compared to last year’s fourth fiscal quarter and equivalent to approximately 58% of total revenue

 

   

GAAP diluted EPS of $1.01, above the midpoint $0.95-$1.03 guidance range

 

   

Non-GAAP diluted EPS of $1.23, above the $1.16-$1.22 guidance range

 

   

GAAP operating income of $147 million; GAAP operating margin of 14.0%

 

   

Non-GAAP operating income of $181 million; non-GAAP operating margin of 17.2%

 

   

Quarterly free cash flow of $145 million, comprised of cash flow from operations of $205 million, less $60 million in net capital expenditures and other; normalized free cash flow of $161 million (1)

 

(1)

Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding).


   

Record twelve-month backlog of $3.62 billion, up $140 million sequentially and up 3.7% as compared to last year’s fourth fiscal quarter

 

   

The board of directors approved a quarterly cash dividend of $0.3275 per share to be paid on January 22, 2021

 

   

The board of directors also approved a 10% increase in the Company’s quarterly cash dividend payment from $0.3275 per share to $0.36 per share, anticipated to be first paid in April 2021, subject to shareholder approval at the January 2021 annual meeting

ST. LOUIS – November 10, 2020 – Amdocs Limited (NASDAQ: DOX) today reported operating results for the three months ended September 30, 2020.

“I am pleased to report a return to sequential revenue growth in our fourth fiscal quarter, primarily driven by healthy activity levels in North America and the ramp-up of new customer engagements in Europe, where we had our best-ever performance. At the operating level, we accelerated our R&D investments while maintaining consistent project execution and stable profitability. Amid the ongoing global pandemic, our sales momentum also accelerated, as reflected in our record 12-month backlog which grew $140 million sequentially and 3.7% year-over-year,” said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

Sheffer continued, “Over the last few months, we have taken several steps to accelerate our growth strategy around 5G and the cloud. The post-merger integration of Openet is proceeding well and we are happy to report a new award at AT&T, which has selected Openet’s 5G solution to quickly launch and monetize exciting new 5G services on the cloud. Additionally, we have signed a new multi-year strategic agreement with AWS as part of which we will bring our cloud-native BSS offerings and wide range of services to jointly address the rapidly growing cloud market in the coming years. As part of another move to focus on our strategy, we have also signed an agreement for the divestiture of OpenMarket for approximately $300 million cash with Infobip, a company in which One Equity Partners is the primary institutional investor. With this transaction, Amdocs is divesting a non-strategic asset in the mobile messaging domain and remaining laser-focused on our core strategic growth initiatives.”


Sheffer concluded, “Turning to our fiscal 2021 outlook, I am happy to report an expected acceleration in growth, with revenue projected to increase at more than twice the rate of last year in constant currency. This outlook is based on the visibility of our record 12-month backlog, the full-year consolidation of Openet and the ramp-up of customer activities across strategic growth areas, including 5G and the cloud.”

Revenue

Revenue for the fourth fiscal quarter ended September 30, 2020 was $1,053 million, up $27 million sequentially from the third fiscal quarter of 2020. Revenue was up 2.2% as reported and 1.8% in constant currency as compared to last year’s fourth fiscal quarter. Revenue for the fourth fiscal quarter of 2020 includes a positive impact from foreign currency movements of approximately $11 million relative to the third quarter of fiscal 2020. Revenue was slightly above the midpoint of Amdocs’ guidance after adjusting for the positive impact of approximately $7 million of foreign currency movements relative to guidance assumptions and revenue from Openet, which was not included in the fourth quarter guidance range.

Revenue for the fiscal year ended September 30, 2020, was $4.2 billion, up 2.0% from the last fiscal year and consistent with the high-end of Amdocs’ guidance range for growth of 1.1% to 2.1% year-over-year as reported. Adjusting for the negative impact of foreign currency movements, revenue was up 2.4% from the last fiscal year and consistent with the high-end of Amdocs’ guidance range for growth of 1.6% to 2.6% year-over-year.

Net Income and Earnings Per Share

The Company’s GAAP net income for the fourth quarter of fiscal 2020 was $134.5 million, or $1.01 per diluted share, compared to GAAP net income of $122.0 million, or $0.90 per diluted share, in the prior fiscal year’s fourth quarter. Net income on a non-GAAP basis was $162.7 million, or $1.23 per diluted share, compared to non-GAAP net income of $147.1


million, or $1.08 per diluted share, in the fourth quarter of fiscal 2019. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, equity-based compensation expenses and other, net of related tax effects, in the fourth quarter of fiscal 2020 and in the fourth quarter of fiscal 2019.

The Company’s GAAP net income in fiscal 2020 was $497.8 million, or $3.71 per diluted share, compared to GAAP net income of $479.4 million, or $3.47 per diluted share, in fiscal 2019. Fiscal 2020 net income on a non-GAAP basis was $595.8 million, or $4.44 per diluted share, compared to non-GAAP net income of $595.1 million, or $4.31 per diluted share, in fiscal 2019. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, equity-based compensation expenses and other, net of related tax effects, in fiscal years 2020 and 2019.

For further details of reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.

Returning Cash to Shareholders

 

   

Quarterly Cash Dividend Program: On November 10, 2020, the Board approved the Company’s next quarterly cash dividend payment of $0.3275 per share and set December 31, 2020 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on January 22, 2021. The Board also approved a 10% increase in the Company’s quarterly cash dividend payment to $0.36 per share, which is anticipated to be first paid in April 2021, provided that the increase is approved by shareholders at the January 2021 annual general meeting of shareholders.

 

   

Share Repurchase Activity: Repurchased $91 million of ordinary shares during the fourth quarter of fiscal 2020.


Twelve-month Backlog

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.62 billion at the end of the fourth quarter of fiscal 2020, up $140 million from the end of the prior quarter and up 3.7% as compared to last year’s fourth fiscal quarter.

First Quarter Fiscal 2021 Outlook

 

   

Revenue of approximately $1,055-$1,095 million, assuming approximately $2 million sequential negative impact from foreign currency fluctuations as compared to the fourth quarter of fiscal 2020 and a full quarter revenue contribution from the acquisition of Openet

 

   

GAAP diluted EPS of approximately $0.85-$0.93

 

   

Non-GAAP diluted EPS of approximately $1.09-$1.15, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately $0.08-$0.10 per share of equity-based compensation expense, net of related tax effects

Full Year Fiscal 2021 Outlook

 

   

Revenue growth of 4.0%-8.0% year-over-year as reported

 

   

Revenue growth of 3.5%-7.5% year-over-year on a constant currency basis

 

   

Full year fiscal 2021 revenue guidance incorporates roughly 1.5% of growth from the acquisition of Openet, and an expected positive impact from foreign currency fluctuations of about 0.5% year-over-year

 

   

GAAP diluted earnings per share growth of roughly 1.5%-8.5% year-over-year

 

   

Non-GAAP diluted earnings per share growth of roughly 5.0%-9.0% year-over-year, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately $0.32-$0.40 per share of equity-based compensation expense, net of related tax effects. The impact of the acquisition of Openet on Amdocs’ non-GAAP diluted earnings per share is expected to be neutral in fiscal year 2021, and accretive thereafter

 


   

Free cash flow of approximately $470 million, comprised of cash flow from operations, less net capital expenditures and other

 

   

Normalized free cash flow of approximately $620 million; normalized free cash flow excludes capital expenditure of up to $150 million related to the new campus development in Israel, and other items

 

   

Divestiture of OpenMarket is expected to close within the next few months, at which time the full fiscal year 2021 outlook will be updated, as the current 2021 outlook includes anticipated full year results from OpenMarket

Our first fiscal quarter 2021 and full year fiscal 2021 outlook takes into consideration the Company’s current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from the COVID-19 pandemic, which has created, and continues to create, a significant amount of uncertainty, and from T-Mobile’s completed merger with Sprint, or from other current and potential customer consolidation activity.

Conference Call Details

Amdocs will host a conference call on November 10, 2020 at 5:00 p.m. Eastern Time to discuss the Company’s fourth quarter of fiscal 2020 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 4156067. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.


Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:     

 

   

amortization of purchased intangible assets and other acquisition-related costs;

 

   

changes in certain acquisition-related liabilities measured at fair value;

 

   

non-recurring and unusual charges;

 

   

equity-based compensation expense;

 

   

other; and

 

   

tax effects related to the above.

Free cash flow equals cash generated by operating activities less net capital expenditures and other. Normalized free cash flow, a measure of our operating performance, is further adjusted to exclude net capital expenditures related to the new campus development, payments for previously expensed restructuring charges, payments for legal dispute settlement, and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in


conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, non-recurring and unusual charges, equity-based compensation expense, other and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

 

   

Keep up with Amdocs news by visiting the Company’s website

 

   

Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube


About Amdocs

Amdocs’ purpose is to enrich lives and progress society, using creativity and technology to build a better connected world. Amdocs and its 26,000 employees partner with the leading players in the communications and media industry, enabling next-generation experiences in 85 countries. Our cloud-native, open and dynamic portfolio of digital solutions, platforms and services brings greater choice, faster time to market and flexibility, to better meet the evolving needs of our customers as they drive growth, transform and take their business to the cloud. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.2 billion in fiscal 2020.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, the duration and severity of the COVID-19 pandemic, and its impact on the global economy, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2019 filed on December 16, 2019 and our Form 6-K furnished for the first quarter of fiscal 2020 on February 18, 2020 and for the second quarter of fiscal 2020 on May 18, 2020 and for the third quarter of fiscal 2020 on August 17, 2020.


Contact:

Matthew Smith

Head of Investor Relations

Amdocs

314-212-8328

E-mail: dox_info@amdocs.com


AMDOCS LIMITED

Consolidated Statements of Income

(in thousands, except per share data)

 

     Three months ended      Fiscal year ended  
     September 30,      September 30,  
     2020     2019      2020     2019  

Revenue

   $ 1,052,948     $ 1,030,253      $ 4,169,039     $ 4,086,669  

Operating expenses:

         

Cost of revenue

     703,556       667,129        2,755,563       2,653,172  

Research and development

     75,843       70,109        282,042       273,936  

Selling, general and administrative

     106,352       125,046        458,539       492,457  

Amortization of purchased intangible assets and other

     20,259       23,815        78,137       97,358  
  

 

 

   

 

 

    

 

 

   

 

 

 
     906,010       886,099        3,574,281       3,516,923  
  

 

 

   

 

 

    

 

 

   

 

 

 

Operating income

     146,938       144,154        594,758       569,746  

Interest and other (expense) income, net

     (6,377     2,444        (11,436     (1,859
  

 

 

   

 

 

    

 

 

   

 

 

 

Income before income taxes

     140,561       146,598        583,322       567,887  

Income taxes

     6,098       24,571        85,482       88,441  
  

 

 

   

 

 

    

 

 

   

 

 

 

Net income

   $ 134,463     $ 122,027      $ 497,840     $ 479,446  
  

 

 

   

 

 

    

 

 

   

 

 

 

Basic earnings per share

   $ 1.02     $ 0.90      $ 3.73     $ 3.49  
  

 

 

   

 

 

    

 

 

   

 

 

 

Diluted earnings per share

   $ 1.01     $ 0.90      $ 3.71     $ 3.47  
  

 

 

   

 

 

    

 

 

   

 

 

 

Basic weighted average number of shares outstanding

     132,330       135,317        133,590       137,418  
  

 

 

   

 

 

    

 

 

   

 

 

 

Diluted weighted average number of shares outstanding

     132,661       136,151        134,232       138,108  
  

 

 

   

 

 

    

 

 

   

 

 

 

Cash dividends declared per share

   $ 0.3275     $ 0.285      $ 1.2675     $ 1.105  
  

 

 

   

 

 

    

 

 

   

 

 

 


AMDOCS LIMITED

Selected Financial Metrics

(In thousands, except per share data)

 

     Three months ended      Fiscal year ended  
     September 30,      September 30,  
     2020      2019      2020      2019  

Revenue

   $ 1,052,948      $ 1,030,253      $ 4,169,039      $ 4,086,669  

Non-GAAP operating income

     181,082        177,989        715,022        707,889  

Non-GAAP net income

     162,716        147,137        595,758        595,089  

Non-GAAP diluted earnings per share

   $ 1.23      $ 1.08      $ 4.44      $ 4.31  

Diluted weighted average number of shares outstanding

     132,661        136,151        134,232        138,108  

Free Cash Flows and Normalized Free Cash Flow

(In thousands)

 

     Three months ended      Fiscal year ended  
     September 30,      September 30,  
     2020      2019      2020      2019  

Net Cash Provided by Operating Activities

   $ 204,680      $ 213,625      $ 658,136      $ 656,377  

Purchases of property and equipment, net (*)

     (59,555      (34,325      (205,510      (128,086
  

 

 

    

 

 

    

 

 

    

 

 

 

Free Cash Flow

     145,125        179,300        452,626        528,291  

Payments for legal dispute settlement

     —          —          —          55,000  

Payment of acquisition related liabilities

     —          —          9,417        7,667  

Payments for previously expensed restructuring charges

     214        1,233        2,143        15,627  

Net capital expenditures related to the new campus development (*)

     15,975        9,101        62,727        6,895  
  

 

 

    

 

 

    

 

 

    

 

 

 

Normalized Free Cash Flow

   $ 161,314      $ 189,634      $ 526,913      $ 613,480  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(*)

The amounts under “Purchase of property and equipment, net” and the amounts under “Net capital expenditures related to the new campus development”, include proceeds from sale of property and equipment of $194 and $151, for the fiscal year ended September 30, 2020 and 2019, respectively, and proceeds of $9,676 relating to the refund of betterment levy, for the fiscal year ended September 30, 2019 ($4,776 of which was a refund to the noncontrolling interests).


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

 

     Three months ended
September 30, 2020
 
           Reconciliation items        
     GAAP     Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in certain
acquisitions related
liabilities measured
at fair value
    Other     Tax
effect
    Non-GAAP  

Operating expenses:

              

Cost of revenue

   $ 703,556     $ —       $ (4,981   $ (4,021   $     $ —       $ 694,554  

Research and development

     75,843       —         (821     —         —         —         75,022  

Selling, general and administrative

     106,352       —         (4,062     —         —         —         102,290  

Amortization of purchased intangible assets and other

     20,259       (20,259     —         —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     906,010       (20,259     (9,864     (4,021     —         —         871,866  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     146,938       20,259       9,864       4,021       —         —         181,082  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest and other (expense) income, net

     (6,377     —         —         —         (600     —         (6,977
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     6,098       —         —         —         —         5,291       11,389  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 134,463     $ 20,259     $ 9,864     $ 4,021     $ (600   $ (5,291   $ 162,716  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Three months ended
September 30, 2019
 
            Reconciliation items        
     GAAP      Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in certain
acquisitions related
liabilities measured
at fair value
    Other     Tax
effect
    Non-GAAP  

Operating expenses:

               

Cost of revenue

   $ 667,129      $ —       $ (4,618   $ (2,036   $ —       $ —       $ 660,475  

Research and development

     70,109        —         (757     —         —         —         69,352  

Selling, general and administrative

     125,046        —         (2,609     —         —         —         122,437  

Amortization of purchased intangible assets and other

     23,815        (23,815     —         —         —         —         —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     886,099        (23,815     (7,984     (2,036     —         —         852,264  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     144,154        23,815       7,984       2,036       —         —         177,989  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest and other income (expense), net

     2,444        —         —         —         (4,964     —         (2,520
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     24,571        —         —         —         —         3,761       28,332  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 122,027      $ 23,815     $ 7,984     $ 2,036     $ (4,964   $ (3,761   $ 147,137  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

 

     Fiscal year ended
September 30, 2020
 
           Reconciliation items        
     GAAP     Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in certain
acquisitions
related liabilities
measured at fair
value
    Other     Tax
effect
    Non-GAAP  

Operating expenses:

              

Cost of revenue

   $ 2,755,563     $ —       $ (20,005   $ 307     $ —       $ —       $ 2,735,865  

Research and development

     282,042       —         (3,058     —         —         —         278,984  

Selling, general and administrative

     458,539       —         (19,371     —         —         —         439,168  

Amortization of purchased intangible assets and other

     78,137       (78,137     —         —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     3,574,281       (78,137     (42,434     307       —         —         3,454,017  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     594,758       78,137       42,434       (307     —         —         715,022  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest and other (expense) income, net

     (11,436     —         —         —         (600     —         (12,036
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     85,482       —         —         —         —         21,746       107,228  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 497,840     $ 78,137     $ 42,434     $ (307   $ (600   $ (21,746   $ 595,758  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Fiscal year ended
September 30, 2019
 
           Reconciliation items        
     GAAP     Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in certain
acquisitions
related liabilities
measured at fair
value
    Other     Tax
effect
    Non-GAAP  

Operating expenses:

              

Cost of revenue

   $ 2,653,172     $ —       $ (19,879   $ (2,235   $ —       $ —       $ 2,631,058  

Research and development

     273,936       —         (2,714     —         —         —         271,222  

Selling, general and administrative

     492,457       —         (15,957     —         —         —         476,500  

Amortization of purchased intangible assets and other

     97,358       (97,358     —         —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     3,516,923       (97,358     (38,550     (2,235     —         —         3,378,780  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     569,746       97,358       38,550       2,235       —         —         707,889  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest and other income (expense), net

     (1,859     —         —         —         (2,939     —         (4,798
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     88,441       —         —         —         —         19,561       108,002  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 479,446     $ 97,358     $ 38,550     $ 2,235     $ (2,939   $ (19,561   $ 595,089  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(In thousands)

 

     As of  
     September 30,
2020
     September 30,
2019
 

ASSETS

     

Current assets

     

Cash and cash equivalents

   $ 983,188      $ 471,632  

Short-term interest-bearing investments

     752        —    

Accounts receivable, net, including unbilled of $175,548 and $227,061, respectively

     861,033        987,858  

Prepaid expenses and other current assets

     229,604        216,084  
  

 

 

    

 

 

 

Total current assets

     2,074,577        1,675,574  

Property and equipment, net

     607,951        525,314  

Lease assets

     295,494        —    

Goodwill and other intangible assets, net

     2,874,979        2,667,997  

Other noncurrent assets

     488,620        423,941  
  

 

 

    

 

 

 

Total assets

   $ 6,341,621      $ 5,292,826  
  

 

 

    

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

     

Current liabilities

     

Accounts payable, accruals and other

   $ 930,259      $ 1,089,748  

Short-term financing arrangements

     100,000        —    

Lease liabilities

     59,100        —    

Deferred revenue

     126,841        118,182  
  

 

 

    

 

 

 

Total current liabilities

     1,216,200        1,207,930  

Lease liabilities

     230,076        —    

Long-term debt, net of unamortized debt issuance costs

     644,023        —    

Other noncurrent liabilities

     586,167        542,430  

Total Amdocs Limited Shareholders’ equity

     3,622,646        3,499,957  

Noncontrolling interests

     42,509        42,509  
  

 

 

    

 

 

 

Total equity

     3,665,155        3,542,466  
  

 

 

    

 

 

 

Total liabilities and equity

   $ 6,341,621      $ 5,292,826  
  

 

 

    

 

 

 


AMDOCS LIMITED

Consolidated Statements of Cash Flows

(In thousands)

 

     Fiscal year ended
September 30,
 
     2020     2019  

Cash Flow from Operating Activities:

    

Net income

   $ 497,840     $ 479,446  

Reconciliation of net income to net cash provided by operating activities:

    

Depreciation and amortization

     198,409       205,772  

Amortization of debt issuance costs

     144       —    

Equity-based compensation expense

     42,434       38,550  

Deferred income taxes

     30,239       (13,950

Loss from short-term interest-bearing investments

     —         737  

Net changes in operating assets and liabilities, net of amounts acquired:

    

Accounts receivable, net

     134,584       6,589  

Prepaid expenses and other current assets

     (10,815     25,907  

Other noncurrent assets

     (23,329     (1,635

Lease assets and liabilities, net

     (7,881     —    

Accounts payable, accrued expenses and accrued personnel

     (190,354     (60,042

Deferred revenue

     (15,184     (37,855

Income taxes payable, net

     (9,281     6,025  

Other noncurrent liabilities

     11,330       6,833  
  

 

 

   

 

 

 

Net cash provided by operating activities

     658,136       656,377  
  

 

 

   

 

 

 

Cash Flow from Investing Activities:

    

Purchases of property and equipment, net (*)

     (205,510     (128,086

Proceeds from sale of short-term interest-bearing investments

     —         101,287  

Purchase of short-term interest-bearing investments

     (753     —    

Net cash paid for business and intangible assets acquisitions

     (249,358     (60,572

Other

     (6,104     615  
  

 

 

   

 

 

 

Net cash used in investing activities

     (461,725     (86,756
  

 

 

   

 

 

 

Cash Flow from Financing Activities:

    

Borrowings under financing arrangements

     450,000       —    

Payments of financing arrangements

     (350,000     —    

Proceeds from issuance of debt, net

     643,919       —    

Repurchase of shares

     (360,912     (398,057

Proceeds from employee stock options exercised

     97,850       41,483  

Payments of dividends

     (164,061     (147,616

Investment by noncontrolling interests, net (*)

     —         (4,776

Payment of contingent consideration from a business acquisition

     (1,411     (7,470

Other

     (240     (336
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     315,145       (516,772
  

 

 

   

 

 

 

Net increase in cash and cash equivalents

     511,556       52,849  

Cash and cash equivalents at beginning of period

     471,632       418,783  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 983,188     $ 471,632  
  

 

 

   

 

 

 

 

(*)

The amounts under “Purchase of property and equipment, net”, include proceeds from sale of property and equipment of $194 and $151, for the fiscal year ended September 30, 2020 and 2019, respectively, and proceeds of $9,676 relating to the refund of betterment levy for the fiscal year ended September 30, 2019 ($4,776 of which was a refund to the noncontrolling interests).


AMDOCS LIMITED

Supplementary Information

(In millions)

 

     Three months ended  
     September 30,
2020
     June 30,
2020
     March 31,
2020
     December 31,
2019
     September 30,
2019
 

North America

   $ 681.6      $ 685.9      $ 691.3      $ 662.1      $ 644.2  

Europe

     165.3        145.4        148.3        154.7        156.1  

Rest of the World

     206.0        194.9        208.3        225.2        230.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 1,052.9      $ 1,026.2      $ 1,047.9      $ 1,042.0      $ 1,030.3  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three months ended  
     September 30,
2020
     June 30,
2020
     March 31,
2020
     December 31,
2019
     September 30,
2019
 

Managed Services Revenue

   $ 610.5      $ 604.5      $ 604.0      $ 579.7      $ 583.3  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     As of  
     September 30,
2020
     June 30,
2020
     March 31,
2020
     December 31,
2019
     September 30,
2019
 

12-Month Backlog

   $ 3,620      $ 3,480      $ 3,460      $ 3,520      $ 3,490  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

# # #